CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
CORT on Nasdaq
Shares outstanding
105,274,735
Price per share
$34.80
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
76,020,485
Total reported value
$2,648,062,770
% of total 13F portfolios
0%
Share change
-1,032,151
Value change
-$156,666,514
Number of holders
374
Price from insider filings
$34.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11% -14% $846,969,867 -$132,857,230 11,539,099 -14% BlackRock, Inc. 30 Jun 2025
INGALLS & SNYDER LLC 7.8% $598,561,589 8,173,721 INGALLS & SNYDER LLC 31 Dec 2024
BELANOFF JOSEPH K 6.3% $499,599,592 6,822,335 Joseph K. Belanoff 31 Dec 2024
RENAISSANCE TECHNOLOGIES LLC 5.5% $200,396,774 5,758,528 Renaissance Technologies LLC 31 Dec 2025

As of 31 Dec 2025, 374 institutional investors reported holding 76,020,485 shares of CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT). This represents 72% of the company’s total 105,274,735 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 12,062,212 +0.12% 0.01% $419,764,959
VANGUARD GROUP INC 9% 9,494,822 -0.44% 0% $330,419,806
INGALLS & SNYDER LLC 6.8% 7,195,060 -6.5% 9.2% $250,388,000
RENAISSANCE TECHNOLOGIES LLC 5.5% 5,758,528 -5.4% 0.31% $200,396,774
Parallel Advisors, LLC 3.7% 3,879,141 +0.2% 2.5% $134,994,107
STATE STREET CORP 2.8% 2,986,056 +0.53% 0% $103,914,749
GEODE CAPITAL MANAGEMENT, LLC 2.5% 2,668,918 +38% 0.01% $92,891,503
FMR LLC 2.3% 2,414,640 +9.7% 0% $84,029,460
DIMENSIONAL FUND ADVISORS LP 1.5% 1,611,779 -15% 0.01% $56,089,910
MORGAN STANLEY 1.5% 1,592,059 +34% 0% $55,403,726
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 1,062,101 -0.76% 0.01% $36,961,115
TD Asset Management Inc 0.94% 994,844 +4% 0.03% $34,620,571
AQR CAPITAL MANAGEMENT LLC 0.84% 887,861 -41% 0.02% $30,897,556
CITADEL ADVISORS LLC 0.82% 863,052 +673% 0.02% $30,034,209
JPMORGAN CHASE & CO 0.79% 834,449 -1.8% 0% $29,038,827
Invesco Ltd. 0.78% 816,996 +12% 0% $28,431,460
Epoch Investment Partners, Inc. 0.78% 816,652 -3.6% 0.16% $28,419,490
Cerity Partners LLC 0.72% 755,295 -0.41% 0.04% $26,284,265
NORGES BANK 0.66% 695,766 0% $24,212,657
FIRST TRUST ADVISORS LP 0.66% 693,317 -3.7% 0.02% $24,127,437
NORTHERN TRUST CORP 0.6% 629,075 -2.1% 0% $21,891,811
Bank of New York Mellon Corp 0.55% 581,656 -3.3% 0% $20,241,613
Boston Trust Walden Corp 0.5% 527,626 -6.2% 0.14% $18,361,385
Allspring Global Investments Holdings, LLC 0.48% 507,967 +112% 0.03% $19,404,339
Clearbridge Investments, LLC 0.48% 507,354 -56% 0.01% $17,655,914

Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 76,020,485 $2,648,062,770 -$156,666,514 $34.80 374
2025 Q3 77,164,189 $6,408,718,399 -$134,980,159 $83.11 423
2025 Q2 78,953,366 $5,792,808,674 -$256,092,991 $73.40 418
2025 Q1 81,954,269 $9,118,688,561 -$126,808,558 $114.22 408
2024 Q4 84,197,994 $4,242,065,667 -$207,314,469 $50.39 362
2024 Q3 88,403,089 $4,090,692,212 +$3,394,284 $46.28 316
2024 Q2 89,225,655 $2,899,048,485 -$128,567,810 $32.49 282
2024 Q1 93,600,393 $2,357,405,516 +$206,853,940 $25.19 283
2023 Q4 84,732,406 $2,752,093,285 +$61,774,959 $32.48 269
2023 Q3 83,019,792 $2,261,938,980 +$53,168,814 $27.24 244
2023 Q2 81,489,147 $1,813,024,077 -$128,901,748 $22.25 224
2023 Q1 87,299,563 $1,890,881,420 +$97,037,592 $21.66 231
2022 Q4 83,493,481 $1,696,055,001 -$86,283,839 $20.31 241
2022 Q3 87,114,680 $2,234,275,240 +$46,310,026 $25.64 225
2022 Q2 85,057,351 $2,023,773,420 +$98,901,040 $23.78 214
2022 Q1 81,373,846 $1,836,938,219 +$19,570,522 $22.52 214
2021 Q4 80,562,329 $1,594,701,243 -$8,205,377 $19.80 199
2021 Q3 80,869,592 $1,591,453,895 +$4,936,347 $19.68 193
2021 Q2 80,507,190 $1,769,402,198 -$27,080,717 $22.00 193
2021 Q1 81,631,723 $1,941,273,564 -$37,899,526 $23.79 205
2020 Q4 83,389,910 $2,180,799,586 -$129,685,932 $26.16 219
2020 Q3 89,228,523 $1,552,636,140 +$5,152,396 $17.40 215
2020 Q2 89,585,381 $1,506,658,948 +$28,288,519 $16.82 215
2020 Q1 88,309,062 $1,050,027,497 -$9,509,056 $11.89 198
2019 Q4 89,063,766 $1,077,729,997 +$45,482,106 $12.10 199
2019 Q3 85,131,011 $1,203,527,878 -$5,445,594 $14.13 190
2019 Q2 86,279,264 $961,989,210 -$5,849,517 $11.15 178
2019 Q1 87,458,593 $1,027,102,142 -$43,866,557 $11.74 202
2018 Q4 90,986,215 $1,215,139,760 +$16,037,355 $13.36 218
2018 Q3 89,613,248 $1,256,182,217 +$22,194,353 $14.02 201
2018 Q2 87,598,857 $1,376,792,174 -$4,897,891 $15.72 212
2018 Q1 87,899,835 $1,446,070,158 -$15,306,978 $16.45 210
2017 Q4 88,793,405 $1,603,715,912 +$258,953,650 $18.06 184
2017 Q3 74,126,241 $1,430,343,350 +$88,254,904 $19.30 188
2017 Q2 69,833,354 $824,271,874 +$108,930,274 $11.80 155
2017 Q1 60,673,852 $664,929,310 +$151,136,418 $10.96 133
2016 Q4 53,330,829 $387,201,104 +$44,065,843 $7.26 135
2016 Q3 47,182,349 $306,733,706 +$9,894,257 $6.50 110
2016 Q2 45,723,356 $249,638,429 +$64,877,791 $5.46 109
2016 Q1 33,883,343 $158,556,671 -$1,367,110 $4.68 95
2015 Q4 34,152,793 $170,039,914 -$231,311 $4.98 95
2015 Q3 34,255,309 $128,827,965 +$5,433,569 $3.76 94
2015 Q2 32,478,045 $195,173,928 +$11,582,180 $6.01 78
2015 Q1 30,334,599 $169,851,880 +$9,777,388 $5.60 60
2014 Q4 28,775,574 $86,298,641 -$1,434,944 $3.00 50
2014 Q3 29,312,101 $78,551,805 -$1,074,865 $2.68 53
2014 Q2 29,700,124 $83,152,770 -$5,827,268 $2.80 61
2014 Q1 30,460,908 $132,741,801 +$10,483,820 $4.36 58